Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity

被引:203
作者
García-Monzón, C
Martín-Pérez, E
Lo Iacono, O
Fernández-Bermejo, M
Majano, PL
Apolinario, A
Larrañaga, E
Moreno-Otero, R
机构
[1] Hosp Univ Santa Cristina, Hepatol Unit, Madrid 28009, Spain
[2] Hosp Univ Princesa, Dept Surg, Madrid, Spain
[3] Hosp Univ Princesa, Liver Unit, Madrid, Spain
关键词
adhesion molecules; liver fibrosis; nitric oxide; nonalcoholic steatohepatitis; obesity; risk factors;
D O I
10.1016/S0168-8278(00)80301-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Nonalcoholic steatohepatitis is an emerging clinical problem among the obese population. However, risk factors of progression to advanced forms of liver disease in this particular group of patients remain to be defined. Methods: The demographics and clinical and histologic features of 46 obese patients were evaluated. The intrahepatic immunological phenotype was assessed in all liver biopsy samples by immunohistochemistry. Results: Histologic findings of nonalcoholic steatohepatitis were observed in 69.5% of the obese population studied and significant fibrosis was evident in 41% of patients with nonalcoholic steatohepatitis. Age (p=0.003), degree of steatosis (p=0.000002), and grade of inflammation (p=0000) at liver biopsy were independent variables positively associated with fibrosis, Intrahepatic expression levels of several immunologic markers of inflammation as well as nitric oxide derivatives were significantly higher in the severe forms of nonalcoholic steatohepatitis than in the mildest forms. Conclusions: Obese persons with higher age, with greater degrees of hepatic steatosis, and specially those with increased grades of intrahepatic inflammation have the greatest risk for progression to fibrotic liver disease, An oxidative stress-triggered intrahepatic inflammatory response appears to be important in the pathogenesis of nonalcoholic steatohepatitis in obesity.
引用
收藏
页码:716 / 724
页数:9
相关论文
共 51 条
[1]   Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter [J].
Amaro, MJ ;
Bartolomé, J ;
Carreño, V .
HEPATOLOGY, 1999, 29 (03) :915-923
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]  
[Anonymous], 1997, WHO TECHN REP SER
[4]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[5]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[6]   Oxidative damage and tyrosine nitration from peroxynitrite [J].
Beckman, JS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (05) :836-844
[7]   Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes [J].
Berson, A ;
De Beco, V ;
Lettéron, P ;
Robin, MA ;
Moreau, C ;
El Kahwaji, J ;
Verthier, N ;
Feldmann, G ;
Fromenty, B ;
Pessayre, D .
GASTROENTEROLOGY, 1998, 114 (04) :764-774
[8]   LIVER IN OBESITY [J].
BRAILLON, A ;
CAPRON, JP ;
HERVE, MA ;
DEGOTT, C ;
QUENUM, C .
GUT, 1985, 26 (02) :133-139
[9]   Obesity: a time bomb to be defused [J].
Bray, GA .
LANCET, 1998, 352 (9123) :160-161
[10]  
Bray GA, 1996, CIBA F SYMP, V201, P228